184 related articles for article (PubMed ID: 10861844)
41. Epidermal growth factor and hepatocyte growth factor receptors collaborate to induce multiple biological responses in bovine mammary epithelial cells.
Accornero P; Martignani E; Miretti S; Starvaggi Cucuzza L; Baratta M
J Dairy Sci; 2009 Aug; 92(8):3667-75. PubMed ID: 19620648
[TBL] [Abstract][Full Text] [Related]
42. Differential osteopontin expression in phenotypically distinct subclones of murine breast cancer cells mediates metastatic behavior.
Mi Z; Guo H; Wai PY; Gao C; Wei J; Kuo PC
J Biol Chem; 2004 Nov; 279(45):46659-67. PubMed ID: 15347645
[TBL] [Abstract][Full Text] [Related]
43. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
[TBL] [Abstract][Full Text] [Related]
44. A signaling adapter function for alpha6beta4 integrin in the control of HGF-dependent invasive growth.
Trusolino L; Bertotti A; Comoglio PM
Cell; 2001 Nov; 107(5):643-54. PubMed ID: 11733063
[TBL] [Abstract][Full Text] [Related]
45. Hepatocyte growth factor is the most potent endogenous stimulant of rabbit gastric epithelial cell proliferation and migration in primary culture.
Takahashi M; Ota S; Shimada T; Hamada E; Kawabe T; Okudaira T; Matsumura M; Kaneko N; Terano A; Nakamura T
J Clin Invest; 1995 May; 95(5):1994-2003. PubMed ID: 7738166
[TBL] [Abstract][Full Text] [Related]
46. Estrogen attenuates integrin-beta(3)-dependent adventitial fibroblast migration after inhibition of osteopontin production in vascular smooth muscle cells.
Li G; Chen YF; Kelpke SS; Oparil S; Thompson JA
Circulation; 2000 Jun; 101(25):2949-55. PubMed ID: 10869268
[TBL] [Abstract][Full Text] [Related]
47. Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells.
Hui AY; Meens JA; Schick C; Organ SL; Qiao H; Tremblay EA; Schaeffer E; Uniyal S; Chan BM; Elliott BE
J Cell Biochem; 2009 Aug; 107(6):1168-81. PubMed ID: 19533669
[TBL] [Abstract][Full Text] [Related]
48. Recombinant GST-human osteopontin fusion protein is functional in RGD-dependent cell adhesion.
Xuan JW; Hota C; Chambers AF
J Cell Biochem; 1994 Feb; 54(2):247-55. PubMed ID: 8175899
[TBL] [Abstract][Full Text] [Related]
49. Cross talk between c-Met and epidermal growth factor receptor during retinal pigment epithelial wound healing.
Xu KP; Yu FS
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2242-8. PubMed ID: 17460286
[TBL] [Abstract][Full Text] [Related]
50. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
51. The integrin specificity of human recombinant osteopontin.
Caltabiano S; Hum WT; Attwell GJ; Gralnick DN; Budman LJ; Cannistraci AM; Bex FJ
Biochem Pharmacol; 1999 Nov; 58(10):1567-78. PubMed ID: 10535747
[TBL] [Abstract][Full Text] [Related]
52. Osteopontin increases breast cancer cell sensitivity to specific signaling pathway inhibitors in preclinical models.
Mutrie JC; Chambers AF; Tuck AB
Cancer Biol Ther; 2011 Oct; 12(8):680-90. PubMed ID: 21795853
[TBL] [Abstract][Full Text] [Related]
53. Selective adhesion of osteoblastic cells to different integrin ligands induces osteopontin gene expression.
Carvalho RS; Kostenuik PJ; Salih E; Bumann A; Gerstenfeld LC
Matrix Biol; 2003 May; 22(3):241-9. PubMed ID: 12853034
[TBL] [Abstract][Full Text] [Related]
54. Inhibitory action of naphtho[1,2-b]furan-4,5-dione on hepatocyte growth factor-induced migration and invasion of MDA-MB-231 cells: mechanisms of action.
Tsai PC; Chu CL; Tseng CH; Chen YL; Chang LS; Lin SR
Clin Exp Pharmacol Physiol; 2014 Sep; 41(9):716-26. PubMed ID: 24909202
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of Met/HGF receptor and angiogenesis by NK4 leads to suppression of tumor growth and migration in malignant pleural mesothelioma.
Suzuki Y; Sakai K; Ueki J; Xu Q; Nakamura T; Shimada H; Nakamura T; Matsumoto K
Int J Cancer; 2010 Oct; 127(8):1948-57. PubMed ID: 20104519
[TBL] [Abstract][Full Text] [Related]
56. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma.
Abounader R; Ranganathan S; Kim BY; Nichols C; Laterra J
J Neurochem; 2001 Mar; 76(5):1497-508. PubMed ID: 11238734
[TBL] [Abstract][Full Text] [Related]
57. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
58. ERK1/2 and JNKs, but not p38 kinase, are involved in reactive oxygen species-mediated induction of osteopontin gene expression by angiotensin II and interleukin-1beta in adult rat cardiac fibroblasts.
Xie Z; Singh M; Singh K
J Cell Physiol; 2004 Mar; 198(3):399-407. PubMed ID: 14755545
[TBL] [Abstract][Full Text] [Related]
59. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.
Raja R; Kale S; Thorat D; Soundararajan G; Lohite K; Mane A; Karnik S; Kundu GC
Oncogene; 2014 Apr; 33(16):2053-64. PubMed ID: 23728336
[TBL] [Abstract][Full Text] [Related]
60. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure.
Liu Y; Tolbert EM; Lin L; Thursby MA; Sun AM; Nakamura T; Dworkin LD
Kidney Int; 1999 Feb; 55(2):442-53. PubMed ID: 9987069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
